Medistim ASA (OSL:MEDI)

Market Cap	3.43B
Revenue (ttm)	603.92M
Net Income (ttm)	122.88M
Shares Out	18.25M
EPS (ttm)	6.71
PE Ratio	28.02
Forward PE	26.20
Dividend	6.00 (3.19%)
Ex-Dividend Date	May 9, 2025

Volume	1,928
Average Volume	3,600
Open	192.00
Previous Close	196.00
Day's Range	187.50 - 194.50
52-Week Range	130.00 - 219.00
Beta	1.02
RSI	42.80
Earnings Date	Aug 20, 2025

About Medistim ASA

Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Asia, Europe, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in a single system for vascular surgery; MiraQ Ultimate that combines TTFM and ultrasound imaging in a single system for cardiac, vascular, and transplan...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1984
• Employees: 154
• Stock Exchange: Oslo Børs
• Ticker Symbol: MEDI

Financial Performance

In 2024, Medistim ASA's revenue was 556.16 million, an increase of 6.73% compared to the previous year's 521.11 million. Earnings were 103.83 million, an increase of 0.01%.